Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

722 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium.
Fonseca A, Lobo J, Hazard FK, Gell J, Nicholls PK, Weiss RS, Klosterkemper L, Volchenboum SL, Nicholson JC, Frazier AL, Amatruda JF, Bagrodia A, Lockley M, Murray MJ. Fonseca A, et al. Among authors: lobo j. Br J Cancer. 2022 Nov;127(9):1577-1583. doi: 10.1038/s41416-022-02000-4. Epub 2022 Oct 13. Br J Cancer. 2022. PMID: 36229581 Free PMC article. Review.
MicroRNAs for detecting occult genitourinary cancer.
Tavares NT, Lobo J, Bagrodia A. Tavares NT, et al. Among authors: lobo j. Curr Opin Urol. 2024 Jan 1;34(1):20-26. doi: 10.1097/MOU.0000000000001137. Epub 2023 Nov 2. Curr Opin Urol. 2024. PMID: 37916954 Review.
Germ cell tumour subtypes display differential expression of microRNA371a-3p.
Vilela-Salgueiro B, Barros-Silva D, Lobo J, Costa AL, Guimarães R, Cantante M, Lopes P, Braga I, Oliveira J, Henrique R, Jerónimo C. Vilela-Salgueiro B, et al. Among authors: lobo j. Philos Trans R Soc Lond B Biol Sci. 2018 Jun 5;373(1748):20170338. doi: 10.1098/rstb.2017.0338. Philos Trans R Soc Lond B Biol Sci. 2018. PMID: 29685967 Free PMC article.
The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors.
Miranda-Gonçalves V, Lobo J, Guimarães-Teixeira C, Barros-Silva D, Guimarães R, Cantante M, Braga I, Maurício J, Oing C, Honecker F, Nettersheim D, Looijenga LHJ, Henrique R, Jerónimo C. Miranda-Gonçalves V, et al. Among authors: lobo j. J Exp Clin Cancer Res. 2021 Aug 25;40(1):268. doi: 10.1186/s13046-021-02072-9. J Exp Clin Cancer Res. 2021. PMID: 34446080 Free PMC article.
722 results